Oesterling JE - Search Results

1

Prostate-specific antigen and prostatic acid phosphatase: biomolecular and physiologic characteristics.

Bilhartz DL, Tindall DJ, Oesterling JE. Bilhartz DL, et al. Among authors: oesterling je. Urology. 1991 Aug;38(2):95-102. doi: 10.1016/s0090-4295(05)80066-4. Urology. 1991. PMID: 1715106 Review.

2

Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status?

Leo ME, Bilhartz DL, Bergstralh EJ, Oesterling JE. Leo ME, et al. Among authors: oesterling je. J Urol. 1991 Apr;145(4):802-6. doi: 10.1016/s0022-5347(17)38456-2. J Urol. 1991. PMID: 1706440

3

Prostate specific antigen: a critical assessment of the most useful tumor marker for adenocarcinoma of the prostate.

Oesterling JE. Oesterling JE. J Urol. 1991 May;145(5):907-23. doi: 10.1016/s0022-5347(17)38491-4. J Urol. 1991. PMID: 1707989 Review.

4

Prostate-specific antigen and androgen deprivation therapy.

Ruckle HC, Oesterling JE. Ruckle HC, et al. Among authors: oesterling je. World J Urol. 1993;11(4):227-32. doi: 10.1007/BF00185075. World J Urol. 1993. PMID: 7508789 Review.

5

Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia.

Monda JM, Barry MJ, Oesterling JE. Monda JM, et al. Among authors: oesterling je. J Urol. 1994 May;151(5):1291-5. doi: 10.1016/s0022-5347(17)35234-5. J Urol. 1994. PMID: 7512660

6

Biopsy-proved prostate cancer in 100 consecutive men with benign digital rectal examination and elevated serum prostate-specific antigen level. Prevalence and pathologic characteristics.

Guthman DA, Wilson TM, Blute ML, Bergstralh EJ, Zincke H, Oesterling JE. Guthman DA, et al. Among authors: oesterling je. Urology. 1993 Aug;42(2):150-4. doi: 10.1016/0090-4295(93)90638-q. Urology. 1993. PMID: 7690170

7

The effect of digital rectal examination on the serum prostate specific antigen concentration: results of a randomized study.

Chybowski FM, Bergstralh EJ, Oesterling JE. Chybowski FM, et al. Among authors: oesterling je. J Urol. 1992 Jul;148(1):83-6. doi: 10.1016/s0022-5347(17)36517-5. J Urol. 1992. PMID: 1377290 Clinical Trial.

8

Predicting radionuclide bone scan findings in patients with newly diagnosed, untreated prostate cancer: prostate specific antigen is superior to all other clinical parameters.

Chybowski FM, Keller JJ, Bergstralh EJ, Oesterling JE. Chybowski FM, et al. Among authors: oesterling je. J Urol. 1991 Feb;145(2):313-8. doi: 10.1016/s0022-5347(17)38325-8. J Urol. 1991. PMID: 1703240

9

Prostate specific antigen in the preoperative and postoperative evaluation of localized prostatic cancer treated with radical prostatectomy.

Oesterling JE, Chan DW, Epstein JI, Kimball AW Jr, Bruzek DJ, Rock RC, Brendler CB, Walsh PC. Oesterling JE, et al. J Urol. 1988 Apr;139(4):766-72. doi: 10.1016/s0022-5347(17)42630-9. J Urol. 1988. PMID: 2451037

10

Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: the influence of prostate specific antigen cancer density.

Blackwell KL, Bostwick DG, Myers RP, Zincke H, Oesterling JE. Blackwell KL, et al. Among authors: oesterling je. J Urol. 1994 Jun;151(6):1565-70. doi: 10.1016/s0022-5347(17)35303-x. J Urol. 1994. PMID: 7514689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

222 results

Search Page

Filters